Coenzyme Q10 and Chemotherapeutic Toxicity in Breast Cancer Patients
Status:
RECRUITING
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
investigating the potential effect of Coenzyme Q10 in ameliorating and preventing the development of paclitaxel chemotherapeutic toxicity in breast cancer patients